Portolan Capital Management, LLC Harvard Bioscience Inc Transaction History

Portolan Capital Management, LLC

  • $1.13 Billion
  • Q2 2024

A detailed history of Portolan Capital Management, LLC transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Portolan Capital Management, LLC holds 12,000 shares of HBIO stock, worth $32,280. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,000
Previous 697,840 98.28%
Holding current value
$32,280
Previous $2.96 Million 98.85%
% of portfolio
0.0%
Previous 0.23%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$2.77 - $4.63 $1.9 Million - $3.18 Million
-685,840 Reduced 98.28%
12,000 $34,000
Q1 2024

May 15, 2024
BUY
$4.02 - $5.39 $103,193 - $138,361
25,670 Added 3.82%
697,840 $2.96 Million
Q4 2023

Feb 14, 2024
BUY
$4.0 - $5.49 $885,092 - $1.21 Million
221,273 Added 49.07%
672,170 $3.6 Million
Q3 2023

Nov 14, 2023
SELL
$4.0 - $5.82 $1.33 Million - $1.94 Million
-332,694 Reduced 42.46%
450,897 $1.94 Million
Q2 2023

Aug 14, 2023
SELL
$4.19 - $6.16 $1.09 Million - $1.6 Million
-259,955 Reduced 24.91%
783,591 $4.3 Million
Q1 2023

May 15, 2023
SELL
$2.45 - $4.22 $26,347 - $45,381
-10,754 Reduced 1.02%
1,043,546 $4.38 Million
Q4 2022

Feb 13, 2023
SELL
$2.12 - $2.86 $610,116 - $823,082
-287,791 Reduced 21.44%
1,054,300 $2.92 Million
Q3 2022

Nov 14, 2022
SELL
$2.33 - $3.92 $2.59 Million - $4.35 Million
-1,109,770 Reduced 45.26%
1,342,091 $3.44 Million
Q2 2022

Aug 15, 2022
SELL
$3.28 - $6.42 $245,763 - $481,037
-74,928 Reduced 2.97%
2,451,861 $8.83 Million
Q1 2022

May 16, 2022
SELL
$5.16 - $7.14 $61,971 - $85,751
-12,010 Reduced 0.47%
2,526,789 $15.7 Million
Q4 2021

Feb 14, 2022
BUY
$6.37 - $8.18 $1.15 Million - $1.48 Million
180,789 Added 7.67%
2,538,799 $17.9 Million
Q3 2021

Nov 15, 2021
BUY
$6.98 - $8.47 $3.77 Million - $4.57 Million
540,133 Added 29.71%
2,358,010 $16.5 Million
Q2 2021

Aug 16, 2021
BUY
$5.44 - $8.4 $1.13 Million - $1.74 Million
207,064 Added 12.85%
1,817,877 $15.1 Million
Q1 2021

May 17, 2021
BUY
$3.91 - $6.99 $1.06 Million - $1.9 Million
271,631 Added 20.28%
1,610,813 $8.8 Million
Q4 2020

Feb 16, 2021
BUY
$3.0 - $4.5 $1.08 Million - $1.62 Million
360,115 Added 36.78%
1,339,182 $5.75 Million
Q3 2020

Nov 16, 2020
BUY
$2.75 - $4.2 $1.1 Million - $1.68 Million
399,773 Added 69.01%
979,067 $2.95 Million
Q2 2020

Aug 14, 2020
BUY
$2.12 - $3.14 $1.23 Million - $1.82 Million
579,294 New
579,294 $1.8 Million

Others Institutions Holding HBIO

# of Institutions
102
Shares Held
32M
Call Options Held
1.2K
Put Options Held
1.2K
View Full List

About HARVARD BIOSCIENCE INC

HBIO Quotes by TradingView
  • Ticker HBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 41,636,500
  • Market Cap $112M
  • Description
  • Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...
More about HBIO
Track This Portfolio

Track Portolan Capital Management, LLC Portfolio

Follow Portolan Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Portolan Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Portolan Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email